Brief: Flerie's Xintela's XSTEM Shows Safety And Efficacy 24 Months Post-Treatment
23/09/2025 12:04
Sept 23 (Reuters) - Flerie AB FLERIE.ST: XINTELA'S XSTEM SHOWS SAFETY AND EFFICACY 24 MONTHS POST-TREATMENT Source text: ID:nMFN5T0yq7 Further company coverage: FLERIE.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Flerie AB
See all newsBrief: Flerie Q3 Net Asset Value SEK 3,113 Million
Brief: Flerie Portfolio Co Reports Positive Data From Clinical Proof-Of-Mechanism Study
Brief: Flerie Writes Down Value Of Holding In Empros Pharma
Brief: Nasdaq Approves Biosergen's Delisting Application
Brief: Flerie Approves Merger Plan For Flerie And Biosergen